124 related articles for article (PubMed ID: 38149510)
1. Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study.
Colafrancesco S; Celia AI; Baldini C; Quartuccio L; Bartoloni E; Carubbi F; Orlandi M; Barbati C; Pignataro MG; Cerbelli B; Giordano C; Ferro F; Gattamelata A; Giardina F; Izzo R; Longhino S; De Vita S; Gerli R; Giacomelli R; Conti F; Priori R
Clin Exp Rheumatol; 2023 Dec; 41(12):2389-2396. PubMed ID: 38149510
[TBL] [Abstract][Full Text] [Related]
2. Thyroid disease in Sjögren's syndrome.
Jara LJ; Navarro C; Brito-Zerón Mdel P; García-Carrasco M; Escárcega RO; Ramos-Casals M
Clin Rheumatol; 2007 Oct; 26(10):1601-6. PubMed ID: 17558463
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren's syndrome.
Choi BY; Oh HJ; Lee YJ; Song YW
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S9-13. PubMed ID: 26315451
[TBL] [Abstract][Full Text] [Related]
4. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
ter Borg EJ; Kelder JC
Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
[TBL] [Abstract][Full Text] [Related]
5. Fatigue in primary Sjögren's syndrome: is there a link with the fibromyalgia syndrome?
Giles I; Isenberg D
Ann Rheum Dis; 2000 Nov; 59(11):875-8. PubMed ID: 11053064
[TBL] [Abstract][Full Text] [Related]
6. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
[TBL] [Abstract][Full Text] [Related]
7. A lower prevalence of malignant lymphoma in Sjögren's syndrome patients: A cross-sectional study.
Saleh W; Elashry MM; Winn N; Mona M; Katz J; Cha S
Oral Dis; 2023 Nov; 29(8):3313-3324. PubMed ID: 36369668
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
[TBL] [Abstract][Full Text] [Related]
9. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
10. Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER).
Torrente-Segarra V; Corominas H; Sánchez-Piedra C; Fernández-Castro M; Andreu JL; Martínez-Taboada VM; Olivé A; Rosas J; Sánchez-Alonso F;
Clin Exp Rheumatol; 2017; 35 Suppl 105(3):28-34. PubMed ID: 28240585
[TBL] [Abstract][Full Text] [Related]
11. Fibromyalgia in Italian patients with primary Sjögren's syndrome.
Ostuni P; Botsios C; Sfriso P; Punzi L; Chieco-Bianchi F; Semerano L; Grava C; Todesco S
Joint Bone Spine; 2002 Jan; 69(1):51-7. PubMed ID: 11858357
[TBL] [Abstract][Full Text] [Related]
12. Myositis in primary Sjögren's syndrome: data from a multicentre cohort.
Colafrancesco S; Priori R; Gattamelata A; Picarelli G; Minniti A; Brancatisano F; D'Amati G; Giordano C; Cerbelli B; Maset M; Quartuccio L; Bartoloni E; Carubbi F; Cipriani P; Baldini C; Luciano N; De Vita S; Gerli R; Giacomelli R; Bombardieri S; Valesini G
Clin Exp Rheumatol; 2015; 33(4):457-64. PubMed ID: 26088683
[TBL] [Abstract][Full Text] [Related]
13. Sleep disturbances, fibromyalgia and primary Sjögren's syndrome.
Tishler M; Barak Y; Paran D; Yaron M
Clin Exp Rheumatol; 1997; 15(1):71-4. PubMed ID: 9093776
[TBL] [Abstract][Full Text] [Related]
14. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
16. Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease.
Argyropoulou OD; Pezoulas V; Chatzis L; Critselis E; Gandolfo S; Ferro F; Quartuccio L; Donati V; Treppo E; Bassoli CR; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos TE; Mavragani CP; Baldini C; Skopouli FN; Galli M; Fotiadis DΙ; De Vita S; Moutsopoulos HM; Tzioufas AG; Goules AV
Semin Arthritis Rheum; 2020 Oct; 50(5):846-853. PubMed ID: 32896698
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland involvement in autoimmune thyroiditis, with special reference to the degree of association with Sjögren's syndrome.
Warfvinge G; Larsson A; Henricsson V; Ericsson UB; Hansen B; Manthorpe R
Oral Surg Oral Med Oral Pathol; 1992 Sep; 74(3):288-93. PubMed ID: 1407988
[TBL] [Abstract][Full Text] [Related]
19. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
